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Misunderstood MTBE
Your recent article panning methyl-tert-
butyl ether use (EHP 102:913) was
extremely misleading and focused on
unpublished, and therefore not critically
reviewed data, which is inconsistent with
standards ofscientific journals. Given the
confusion caused by the article, you
should provide more accurate information
to your readers on why methyl-tert-butyl
ether (MTBE) is in gasoline and how it is
being managed in a manner protective of
public health.
In 1990, Congress passed the Clean
Air Act Amendments, which contained a
requirement to include oxygen in fuel to
reduce carbon monoxide (CO) emissions
from motor vehicles. Once oxygenates
were required by law, the industry began
the process of tooling up for the produc-
tion of oxygenated fuels. Either alcohols
or ethers can be added to provide oxygen
and both have been used previously.
During the 1979 fuel crisis, alcohols had
been added to gasoline to form gasohol.
MTBE was added to gasoline as an octane
enhancer after the lead phase-out. MTBE
had also been used in a three-year pilot
CO reduction program in the Southwest
beginning in the winter of 1989-1990.
There was a considerable body oftoxi-
cological data on MTBE, including neu-
rotoxicity studies, genetic toxicity studies,
and reproduction and developmental
studies. In addition, preliminary results
were available from chronic bioassays in
rats and mice prior to the onset of the
winter fuels program. These results did
not suggest MTBE would be hazardous,
particularly at the low concentrations
likely to be encountered in fuel use. Thus,
required by law to add an oxygenate,
industry legitimately made MTBE its
principal choice. Ethanol, however, is also
widely used, and other compounds such
as ethyl-tert-butyl ether, tert-amyl methyl
ether, and tert-butyl alcohol are being
considered. Oxygenates have been added
to winter fuel in 39 cities since November
1992 for CO reduction and are now in
reformulated gasoline, which has been
required to be sold in approximately 35
geographic areas to reduce ozone since
January 1, 1995.
How has the oxygenate program
fared? From the standpoint ofCO reduc-
tion, it has been successful. EPA esti-
mates that "a reduction of over 2 billion
pounds of carbon monoxide annually is
associated with the winter program."
There have been a few complaints from
users about reactions to the new product,
something not surprising given MTBE's
very distinctive ether odor. In 1989,
there were a few complaints in the
Southwest, but they disappeared in 1990
and 1991. With the initiation ofthe win-
ter fuel program in 1992, there were scat-
tered complaints in New York, Montana,
and more frequent complaints in Alaska
and New Jersey. Industry responded by
collaborating with EPA to conduct sever-
al studies to assess exposure during nor-
mal activities and attempting to duplicate
exposures to assess health effects in
human volunteers in controlled laborato-
ry situations.
The results of these studies were reas-
suring. Exposures during refueling and
commuting were consistently low, averag-
ing 0.3-0.5 ppm during refueling. Acute
symptoms described in the complaints
could not be replicated in clinical cham-
ber studies (1). Finally, in a study com-
paring healthy garage workers exposed to
high and low MTBE concentrations, no
differences in self-reported symptoms
could be demonstrated that were attribut-
able to MTBE exposure (2).
We still hear reference to complaints
in New Jersey, although principally from
representatives of groups, not from indi-
viduals. We find these complaints per-
plexing since New Jersey law minimizes
exposures by requiring stage II vapor
recovery systems throughout the state
and by not allowing self-service fueling
stations. It is also interesting to note that
oxygenated fuels are widely used in vari-
ous parts of the United States, yet the
complaints appear to be focused in New
Jersey.
In summary, the government mandat-
ed the use ofoxygenates in fuels, and the
industry is complying with that mandate.
There is a large body of toxicologic data
about MTBE, which makes up the largest
fraction of oxygenates currently in use.
That data do not suggest untoward health
effects from the very limited exposures
encountered during normal use of gaso-
line. Both government and industry have
managed introduction of MTBE and
responded to legitimate complaints in an
appropriate manner. The article you pub-
lished was incorrect and misleading and
not representative ofthe quality ofarticles
that should appear in your publication.
Robert T. Drew
American Petroleum Institute
Washington, DC
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Clarification
The November 1994 issue of EHP con-
tained a forum article on methyl-tert-
butyl ether that referred to the North
Carolina scientific Advistory Board's
review of the carcinogenicity data for
MTBE. The conclusion ofthe article stat-
ed that "The Board concluded that the
state should consider requesting that the
EPA remove MTBE from gasoline
because of the uncertainties surrounding
it." This statement is incorrect. We did
not make such a recommnedation. The
following summary represents our report
to the North Carolina Department of
Environment, Health and Natural
Resources.
George Lucier, chair
Mary Beth Genter
Y.J. Lao
Woodhall Stopford
Tom Starr
North Carolina Scientific Advisory Board
on Toxic Air Pollutants
Summary ofthe Carcinogenicity
Assessment ofMTBE conducted by
the Secretary's Scientific Advisory
Board on Toxic Air Pollutants
Abstract. The Secretary's Scientific
Advisory Board on Toxic Air Pollutants
(SAB) examined the scientific evidence
pertaining to MTBE carcinogenicity and
came to a consensus agreement that,
according to the National Toxicology
Program (NTP) classification of carcino-
genic activity, there is "some evidence"
for carcinogenicity of MTBE in animals.
The SAB agreed "some evidence" approx-
imately corresponds to the "C" classifica-
tion by the EPA. In an exception to the
SAB policy of not quantifying risk for
group C carcinogens, a range ofexposures
that could be associated with a potential
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